Several RBPs that are up-regulated in cancer tissue can modulate the expression of genes implicated in cell survival [11, 34], which prompted us to hypothesise that IMP3 could control programmed cell death also in CRC cells. Here, IMP3 is linked to colorectal carcinoma.